These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36629483)

  • 21. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics, treatment patterns, disease burden, and persistence/adherence in patients with asthma initiating inhaled triple therapy: real-world evidence from Japan.
    Suzuki T; Fairburn-Beech J; Sato K; Kaise T
    Curr Med Res Opin; 2020 Jun; 36(6):1049-1057. PubMed ID: 32363945
    [No Abstract]   [Full Text] [Related]  

  • 23. Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD.
    Bourbeau J; Bafadhel M; Barnes NC; Compton C; Di Boscio V; Lipson DA; Jones PW; Martin N; Weiss G; Halpin DMG
    Int J Chron Obstruct Pulmon Dis; 2021; 16():499-517. PubMed ID: 33688176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.
    Langham S; Lewis J; Pooley N; Embleton N; Langham J; Han MK; Chalmers JD
    Respir Res; 2019 Nov; 20(1):242. PubMed ID: 31684965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma.
    Kotoulas SC; Tsiouprou I; Domvri K; Ntontsi P; Pataka A; Porpodis K
    Adv Respir Med; 2023 Jul; 91(4):288-300. PubMed ID: 37489386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management.
    Busse WW; Abbott CB; Germain G; Laliberté F; MacKnight SD; Jung Y; Duh MS; Averell CM
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2904-2913.e6. PubMed ID: 35752431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 28. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study).
    Deslee G; Fabry-Vendrand C; Poccardi N; Thabut G; Eteve Pitsaer C; Coriat A; Renaudat C; Maguire A; Pinto T
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37263738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current appraisal of single inhaler triple therapy in COPD.
    Lipworth B; Kuo CR; Jabbal S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3003-3009. PubMed ID: 30319248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality.
    Suissa S; Dell'Aniello S; Ernst P
    COPD; 2022 Dec; 19(1):1-9. PubMed ID: 34544314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β
    Requena G; Banks V; Czira A; Wood R; Tritton T; Wild R; Compton C; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2023; 18():231-245. PubMed ID: 36908830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease.
    D'Urzo A; Donohue JF; Kardos P; Miravitlles M; Price D
    Expert Opin Pharmacother; 2015; 16(12):1845-60. PubMed ID: 26194213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.
    Feldman WB; Avorn J; Kesselheim AS; Gagne JJ
    JAMA Intern Med; 2023 Jul; 183(7):685-695. PubMed ID: 37213116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
    Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis.
    Oba Y; Anwer S; Maduke T; Patel T; Dias S
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013799. PubMed ID: 36472162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids.
    Liao PA; Pan SW; Chen CY; Deng CY; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2023; 18():553-563. PubMed ID: 37069844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
    Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of COPD patients treated with single‑inhaler triple therapy in real-life clinical practice.
    Lassan S; Keszegh J; Lassanova M
    Bratisl Lek Listy; 2022; 123(1):27-36. PubMed ID: 34967655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016.
    Bloom CI; Elkin SL; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():279-287. PubMed ID: 30774325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.